ARCHIVES

NIH Panel Urges Wider Treatment of Hepatitis C

This article is from The Cancer Letter archive.

Vol. 28 No. 24 | June 14, 2002

Download PDF Visit The Full Archive

Related Articles

Memorial’s Scher Warns FDA About Flaws In Provenge Data, Urges Not To Approve.

April 13, 2007

Avastin doubles progression-free survival in metastatic disease.

May 27, 2005

Only Seven Of 66 “Benign” Breast Cancer Turn Out to Be Doubtful

November 25, 1977

Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable

January 31, 2003

Central Line Safety Intervention Lowers Patient Infection Rate

October 25, 2013

Funding Opportunities: Aging Institute Offers Program Announcement

February 6, 1998